Lymphedema Treatment Registry

Launched by EGE UNIVERSITY · Feb 14, 2020

Keywords

ClinConnect Summary

The Lymphedema Treatment Registry is a clinical trial designed to study women who have lymphedema, a condition that can occur after breast cancer treatment, specifically in its early stages (stage 0 to 2). The trial will look for patients who have had lymphedema for more than six months and have completed their breast cancer treatments. Participants will be assessed based on their medical history and undergo various tests to measure their arm or leg size, overall health, and quality of life before and after a special therapy called complete decongestive therapy.

Eligible participants will be women aged 65 to 74 who have had breast cancer and are experiencing lymphedema. If you join this study, you can expect to have your limb size and quality of life checked several times over two years to see how the therapy helps. It’s important to know that this trial is not yet recruiting participants, and certain health conditions, like severe heart or kidney disease, may exclude some individuals from participating.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Breast cancer
• • Lymphedema more than 6 months
• • Lymphedema stage 0-2
• • Completed treatment (CT-RT)
• Exclusion Criteria:
• • Stage 3 lymphedema
• • Cardiovasculary disease
• • Hepatic disease
• • Kidney disease
• • Cerebrovascular event
• • Metastasis
• • Gastritis
• • Infection
• • Smoking
• • Active cancer
• • Bleeding history